DCX Liquid Cooling Systems has launched new cooling distribution units (CDUs). The company this week announced three new CDU systems built on its proprietary DCX ECDU (Enterprise Coolant Distribution ...

WARSAW, Poland--(BUSINESS WIRE)--DCX Liquid Cooling Systems today unveiled its new ECDU (Enterprise Coolant Distribution Unit) platform, a family of three purpose-built CDU models that deliver real ...

DCX Liquid Cooling Systems has launched a new cooling distribution unit (CDU). The company this week announced the new, second-generation facility distribution unit (FDU V2AT2). The new CDU delivers ...

DCX Liquid Cooling Systems achieved a record breaking 600% surge in revenue. The company hired over 100 new employees, effectively quadrupling its size. WARSAW ...

Behringer is no stranger to remaking classic synthesizers and selling them at much cheaper price points. However, this latest release may just take the budget-friendly cake. The company just ...

Fair trade regulator CCI on Tuesday approved US-based cryptocurrency platform Coinbase's proposal to acquire a minority stake in DCX Global Ltd. The development came after Coinbase Global in October ...

Shares of defence major DCX Systems Ltd have risen 23% in six months, signalling a short-term recovery. However, the stock is still down 6% in three months. In the long term too, the DCX Systems stock ...

From a long-term perspective, we view DCX Systems as structurally well-positioned to benefit from rising defence exports and import substitution initiatives. Its strong order book (2.5x of FY25 ...

Repare Therapeutics Inc. (Repare), a leading clinical-stage precision oncology company, announced that it has out-licensed its discovery platforms, including certain platform and programme ...

Repare Therapeutics has entered an out-licensing agreement with Canadian biotechnology firm DCx Biotherapeutics for discovery platforms and intellectual property (IP). Repare will obtain $4m in ...

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that it has out-licensed its ...

VANCOUVER — DCx Biotherapeutics Corporation (“DCx”) today announced an agreement with Repare Therapeutics Inc. (“Repare”) (NASDAQ: RPTX) to (i) in-license Repare’s discovery platform including certain ...